MARATTO

article · Bioactive Materials

Biodegradable PMMA coated Zn–Mg alloy with bimodal grain structure for orthopedic applications - A promising alternative

202413 citationsOpen accessAin Shams University

Abstract

The study examines the impact of microstructure and polymethyl methacrylate (PMMA) grafting on the degradability of Zn-Mg alloys. The mechanical properties of a Zn alloy containing 0.68 wt% Mg and extruded at 200 °C are enhanced for degradable load-bearing applications, addressing a crucial need in the field. The material exhibits a bimodal grain size distribution that is random texture, consisting of secondary phases, grains, and sub-grains. With an elongation to failure of 16 %, the yield and ultimate tensile strengths are 325.9 and 414.5 MPa, respectively, and the compressive yield strength is 450.5 MPa. The "grafting-from" method was used to coat a few micrometers thick of PMMA on both bulk and scaffold Zn alloys to mitigate the corrosion rate. The last one is a porous structure, with a porosity of 65.8 %, considered as in the first approach of an orthopedic implant. After being immersed for 720 h, the PMMA-grafted bulk alloy's corrosion rate decreased from 0.43 to 0.25 mm/y. Similarly, the scaffold alloy's corrosion rate reduced from 1.24 to 0.49 mm/y. These results indicate that the method employed could be used for future orthopedic applications.

Research topics

  • Magnesium Alloys: Properties and Applications
  • Bone Tissue Engineering Materials
  • Orthopaedic implants and arthroplasty

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.bioactmat.2024.05.031

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.